Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer

Review

|Open Access
Article Access Statistics
  • Viewed

    607

  • Downloaded

    43

See Updates
Table of Contents
Cancer Drug Resistance ISSN 2578-532X (Online)
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.